Trial Profile
Effect of iron containing phosphate binder on iron metabolism of patients undergoing maintenance hemodialysis.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Oct 2016
Price :
$35
*
At a glance
- Drugs Sucroferric oxyhydroxide (Primary)
- Indications Renal failure
- Focus Adverse reactions
- 06 Oct 2016 New trial record